OptimizeRx Corporation (OPRX) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for joining OptimizeRx's second quarter fiscal 2026 earnings conference call. With us today is Chief Executive Officer Stephen Silvestro. He is joined by Chief Financial Strategy Officer Edward Stelmakh, Chief Legal and Administrative Officer Marion Odence-Ford, and Chief Business Officer Andy De Silva. At the conclusion of today's call, I will provide some important cautions regarding the forward-looking statements Thank you for joining us today. With that, I'll turn the call over to OptimizeRx's Chief Executive Officer, Stephen Silvestro. Mr. Silvestro? Thank you, Operator, and good afternoon, everyone. Thank you for joining us for our second quarter 2026 earnings call. We're pleased to report second quarter revenue of $20.5 million and adjusted EBITDA of $4.9 million, both of which exceeded consensus expectations. Our results reflect continued margin expansion, disciplined operational execution, and the resilience of our operating model despite a healthcare marketing environment that remains dynamic. While revenue declined year over year and contracted revenue remains below prior year levels, these declines remain limited to a small number of large customers, including the one customer we discussed last quarter that again did not generate revenue this quarter, as well as customers that have made heavier use of lower margin managed service offerings in prior year periods, services from which We have been transitioning away since the acquisition of Medix in 2023. Outside the business with these limited customers and across the remainder of the business, we are encouraged by improving engagement and growth. At the same time, our continued investment in platform capabilities, including recent product launches and expanded programmatic initiatives, is strengt...